Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from October 22, 2018 up to and including October 25, 2018 a total of 1,818,400 of its own common shares were repurchased, with a weighted average purchase price of EUR 31.70. These repurchases were made under the repurchase program to cover long-term incentive and employee share purchase plans, which was announced on October 22, 2018. Further details can be found via this link.* * Details of Philips’ current EUR 1.5 billion share buyback program for capital reduction purposes, which was initiated in the third quarter of 2017, can be found via the same link.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office Tel: +31 6 1521 3446
You are about to visit a Philips global content page
Continue Philips Investor Relations Tel: +31 20 59 77055
You are about to visit a Philips global content page
ContinueGet our press releases by e-mail
You are about to visit a Philips global content page
Continue